Animal studies indicate that concurrent G-protein αs (GNAS) and KRAS mutations characterize pancreatic ductal adenocarcinomas (PDAs) arising from IPMNs, associated with the induction of lipid remodeling and fatty acid oxidation [9]. Here, KRAS is linked to pancreatic ductal adenocarcinoma.